Provider
P63-17 New Drug-Related PA with Quantity Limit Criteria: Otezla (apremilast)
Program effective Date: Nov 06, 2017
Documents & Forms Results
Displaying 2881 - 2890 of 3097 results
Provider
P64-17 New Drug-Related PA with Quantity Limit Criteria: Biologic Immunomodulators
Program effective Date: Nov 06, 2017
Provider
P65-17 Clarification to Commercial Prior Authorization for Biologic Immunomodulators
Program effective Date: Nov 06, 2017
Provider
P62-17 Addition of Drug to the Parathyroid Hormone Analog for Osteoporosis Prior Authorization with Quantity Limit Program
Program effective Date: Nov 06, 2017
Provider
P67-17 PA Requirements for New Medicare Advantage Prescription Drug Products in 2018
Program effective Date: Nov 06, 2017
Provider
P61-17 FQHC/RHC Clinics Providing Interpreter Services for MHCP Subscribers
Program effective Date: Nov 02, 2017
Provider
QP34-17 New Pre-Authorization Form for Immunoglobulin Therapy
Program effective Date: Nov 01, 2017
Provider
P59-17 Government Programs Subscribers Prior Authorization Requirement for Spinal Fusion: Lumbar
Program effective Date: Nov 01, 2017
Provider
P60-17 2018 Renewal Changes Summary for Institutional Providers
Program effective Date: Nov 01, 2017
Provider
P57-17 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Oct 24, 2017